Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly

BackgroundChronic kidney disease (CKD) is accompanied by increases in circulating fibroblast growth factor 23 (FGF23) and aldosterone levels. Here, we tested the hypothesis that aldosterone may be one of the driving forces behind increased FGF23 secretion in CKD.MethodsUsing data from a prospective...

Full description

Bibliographic Details
Main Authors: Judith Radloff, Maximilian Pagitz, Olena Andrukhova, Rainer Oberbauer, Iwan A. Burgener, Reinhold G. Erben
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.649921/full
_version_ 1831544449550778368
author Judith Radloff
Maximilian Pagitz
Olena Andrukhova
Rainer Oberbauer
Iwan A. Burgener
Reinhold G. Erben
author_facet Judith Radloff
Maximilian Pagitz
Olena Andrukhova
Rainer Oberbauer
Iwan A. Burgener
Reinhold G. Erben
author_sort Judith Radloff
collection DOAJ
description BackgroundChronic kidney disease (CKD) is accompanied by increases in circulating fibroblast growth factor 23 (FGF23) and aldosterone levels. Here, we tested the hypothesis that aldosterone may be one of the driving forces behind increased FGF23 secretion in CKD.MethodsUsing data from a prospective study in humans, a retrospective study in dogs and cats, and an experimental study in 5/6-nephrectomized mice, we analyzed the relationship between circulating FGF23 and serum aldosterone levels in CKD across four species. To assess the effects of acute inhibition of aldosterone signaling on circulating FGF23, we acutely treated mice with established CKD with the mineralocorticoid receptor blocker canrenone (50 mg/kg iv/sc), and measured intact FGF23 before and 24 h as well as 72 h after start of administration of the drug.ResultsWe found a tight positive association between circulating intact FGF23 and serum aldosterone in human, canine, and feline CKD patients, as well as in experimental murine CKD (humans: rS = 0.57, p = 0.0368; dogs: rS = 0.66, p = 0.0019; cats: rS = 0.75, p = 0.0003; mice: rS = 0.49, p = 0.0004). Injection of canrenone in mice with established CKD did not lead to changes in FGF23 levels within 24 h, but reduced FGF23 in all mice at 72 h.ConclusionAldosterone may drive enhanced FGF23 secretion in CKD, possibly explaining the tight positive association between circulating intact FGF23 and aldosterone in human, canine, and feline CKD patients as well as in experimental CKD models.
first_indexed 2024-12-17T01:09:49Z
format Article
id doaj.art-1797c8e9082c41fab3b636715bb7e4a6
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-17T01:09:49Z
publishDate 2021-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-1797c8e9082c41fab3b636715bb7e4a62022-12-21T22:09:10ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2021-04-011210.3389/fphys.2021.649921649921Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion DirectlyJudith Radloff0Maximilian Pagitz1Olena Andrukhova2Rainer Oberbauer3Iwan A. Burgener4Reinhold G. Erben5Department of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, AustriaDivision of Small Animal Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, AustriaDepartment of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, AustriaDepartment of Nephrology, Medical University of Vienna, Vienna, AustriaDivision of Small Animal Internal Medicine, Department for Companion Animals and Horses, University of Veterinary Medicine Vienna, Vienna, AustriaDepartment of Biomedical Sciences, University of Veterinary Medicine Vienna, Vienna, AustriaBackgroundChronic kidney disease (CKD) is accompanied by increases in circulating fibroblast growth factor 23 (FGF23) and aldosterone levels. Here, we tested the hypothesis that aldosterone may be one of the driving forces behind increased FGF23 secretion in CKD.MethodsUsing data from a prospective study in humans, a retrospective study in dogs and cats, and an experimental study in 5/6-nephrectomized mice, we analyzed the relationship between circulating FGF23 and serum aldosterone levels in CKD across four species. To assess the effects of acute inhibition of aldosterone signaling on circulating FGF23, we acutely treated mice with established CKD with the mineralocorticoid receptor blocker canrenone (50 mg/kg iv/sc), and measured intact FGF23 before and 24 h as well as 72 h after start of administration of the drug.ResultsWe found a tight positive association between circulating intact FGF23 and serum aldosterone in human, canine, and feline CKD patients, as well as in experimental murine CKD (humans: rS = 0.57, p = 0.0368; dogs: rS = 0.66, p = 0.0019; cats: rS = 0.75, p = 0.0003; mice: rS = 0.49, p = 0.0004). Injection of canrenone in mice with established CKD did not lead to changes in FGF23 levels within 24 h, but reduced FGF23 in all mice at 72 h.ConclusionAldosterone may drive enhanced FGF23 secretion in CKD, possibly explaining the tight positive association between circulating intact FGF23 and aldosterone in human, canine, and feline CKD patients as well as in experimental CKD models.https://www.frontiersin.org/articles/10.3389/fphys.2021.649921/fullfibroblast growth factor-23chronic kidney diseasealdosteroneleft ventricular hypertrophydialysiscalcimimetics
spellingShingle Judith Radloff
Maximilian Pagitz
Olena Andrukhova
Rainer Oberbauer
Iwan A. Burgener
Reinhold G. Erben
Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
Frontiers in Physiology
fibroblast growth factor-23
chronic kidney disease
aldosterone
left ventricular hypertrophy
dialysis
calcimimetics
title Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
title_full Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
title_fullStr Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
title_full_unstemmed Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
title_short Aldosterone Is Positively Associated With Circulating FGF23 Levels in Chronic Kidney Disease Across Four Species, and May Drive FGF23 Secretion Directly
title_sort aldosterone is positively associated with circulating fgf23 levels in chronic kidney disease across four species and may drive fgf23 secretion directly
topic fibroblast growth factor-23
chronic kidney disease
aldosterone
left ventricular hypertrophy
dialysis
calcimimetics
url https://www.frontiersin.org/articles/10.3389/fphys.2021.649921/full
work_keys_str_mv AT judithradloff aldosteroneispositivelyassociatedwithcirculatingfgf23levelsinchronickidneydiseaseacrossfourspeciesandmaydrivefgf23secretiondirectly
AT maximilianpagitz aldosteroneispositivelyassociatedwithcirculatingfgf23levelsinchronickidneydiseaseacrossfourspeciesandmaydrivefgf23secretiondirectly
AT olenaandrukhova aldosteroneispositivelyassociatedwithcirculatingfgf23levelsinchronickidneydiseaseacrossfourspeciesandmaydrivefgf23secretiondirectly
AT raineroberbauer aldosteroneispositivelyassociatedwithcirculatingfgf23levelsinchronickidneydiseaseacrossfourspeciesandmaydrivefgf23secretiondirectly
AT iwanaburgener aldosteroneispositivelyassociatedwithcirculatingfgf23levelsinchronickidneydiseaseacrossfourspeciesandmaydrivefgf23secretiondirectly
AT reinholdgerben aldosteroneispositivelyassociatedwithcirculatingfgf23levelsinchronickidneydiseaseacrossfourspeciesandmaydrivefgf23secretiondirectly